Latest News
One turnaround story shows recovery despite revenue headwinds; the other leans on government contracts and strong cash flow. Their valuations tell very different stories.
Via The Motley Fool · August 21, 2026
Bargain hunters are flocking to the discount retailer's stores.
Via The Motley Fool · August 21, 2026
The conglomerate's new CEO spent the second quarter selling the bank Buffett had been selling for two years -- and buying the airline Buffett sold out of in 2020.
Via The Motley Fool · August 21, 2026
The number of stocks moving 10% or more in either direction this past quarter is staggering. The team dissects the results.
Via The Motley Fool · August 21, 2026
Tesla caught two breaks: Nevada regulators cleared it to put as many as 5,000 driverless robotaxis on Las Vegas streets, and its electric semi truck is headed to Germany.
Via The Motley Fool · August 21, 2026
RaceControl subscriptions surged 349%, fueling six consecutive profitable quarters.
Via The Motley Fool · August 21, 2026
AST SpaceMobile burns cash while pursuing satellite broadband, while Boeing grapples with debt and production challenges, both carry distinct risks that reshape the comparison.
Via The Motley Fool · August 21, 2026
The athleisure specialist is struggling, but a strong earnings report can turn momentum around.
Via The Motley Fool · August 21, 2026
On Aug. 21, 2026, Nevada cleared the way for paid autonomous ride-hailing services, fueling investor optimism on its Cybercab fleet deployment.
Via The Motley Fool · August 21, 2026
There are only a few more weeks to go until the biggest Social Security announcement of the year.
Via The Motley Fool · August 21, 2026
Australian cinema hit record highs as consolidated revenue climbed 11%.
Via The Motley Fool · August 21, 2026
Generally speaking, as cryptos go, so goes the company's equity.
Via The Motley Fool · August 21, 2026
LiveRamp (NYSE:RAMP) stockholders approved the company’s proposed merger with MMS USA Holdings Inc. at a virtual special meeting, clearing a key shareholder-vote requirement for the transaction outlined in a May 16, 2026 merger agreement.
The merger proposal received affirmative votes representing
Via MarketBeat · August 21, 2026
Fabrinet trounced earnings expectations, but hopes for an even bigger beat and other macroeconomic factors weighed on shares.
Via The Motley Fool · August 21, 2026
These three high-yield dividend stocks look ideal to boost your passive income.
Via The Motley Fool · August 21, 2026
The Terafab joint venture is set to materially benefit both businesses.
Via The Motley Fool · August 21, 2026
This TSX stock recently increased its quarterly dividend by 3.2%, extending its record of annual dividend increases to 26 consecutive years.
Via The Motley Fool · August 21, 2026
Texas Pacific Land (NYSE:TPL) has outperformed the market over the past 10 years by 54.67% on an annualized basis producing an average annual return of 68.08%. Currently, Texas Pacific Land has a market capitalization
Via Benzinga · August 21, 2026
Veeco Instruments (NASDAQ:VECO) has outperformed the market over the past 5 years by 6.01% on an annualized basis producing an average annual return of 17.32%. Currently, Veeco Instruments has a market capitalization of
Via Benzinga · August 21, 2026
XRP has surged 40% in a week, prompting speculation if it's a short squeeze or the start of a larger crypto expansion.
Via Benzinga · August 21, 2026
The TSX is at record highs, and Suncor could still be a smart buy if cash flow stays strong.
Via The Motley Fool · August 21, 2026
An analyst significantly reduced his price target on the company's equity.
Via The Motley Fool · August 21, 2026
Hess Midstream isn't winning any energy sector popularity contests, but income investors shouldn't overlook this stock.
Via The Motley Fool · August 21, 2026
These two high-yield dividend stocks are ideal for long-term income-seeking investors.
Via The Motley Fool · August 21, 2026
Royalty Pharma (NASDAQ:RPRX) has outperformed the market over the past 10 years by 27.34% on an annualized basis producing an average annual return of 40.75%. Currently, Royalty Pharma has a market capitalization of
Via Benzinga · August 21, 2026